Eurofins Scientific SE Stock OTC Markets
Stocks
ERFSF
FR0014000MR3
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
OTC Markets
23:24:37 16/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 84.33 USD | -2.31% |
|
+0.52% | +15.06% |
| Market Cap | 12.97B 14.96B 12.26B 11.13B 20.86B 1,436B 20.98B 146B 56.54B 728B 56.21B 54.96B 2,321B | P/E 2026 * |
24.9x | P/E 2027 * | 19.7x |
|---|---|---|---|---|---|
| Enterprise Value | 16.33B 18.85B 15.44B 14.02B 26.27B 1,808B 26.43B 184B 71.22B 917B 70.8B 69.23B 2,923B | EV / Sales 2026 * |
2.15x | EV / Sales 2027 * | 2x |
| Free-Float |
60.39% | Yield 2026 * |
1.07% | Yield 2027 * | 1.22% |
| Markets | Quality | ||
|---|---|---|---|
Euronext Paris
| ERF | Real-time | |
CBOE
| Real-time | ||
|
Tradegate
| ESF0 | Real-time | |
|
OTC Markets
| ERFSF | Delayed | |
|
Börse Stuttgart
| ESF0 | Delayed | |
|
Xetra
| ESF0 | Delayed | |
|
CBOE
| 0MV5 | Real-time | |
|
Wiener Boerse
| ESF | End-of-day quote | |
|
Boerse Muenchen
| ESF0 | Real-time | |
|
Deutsche Boerse AG
| ESF0 | Delayed | |
|
London S.E.
| 0MV5 | Delayed | |
|
Borsa Italiana
| 4ERF | End-of-day quote |
Last Transcript: Eurofins Scientific SE
| 1 day | -2.31% | ||
| 1 week | +0.52% | ||
| Current month | +2.00% | ||
| 1 month | +3.24% | ||
| 3 months | +18.44% | ||
| 6 months | +16.90% | ||
| Current year | +15.06% |
| 1 week | 79.74 |  | 87.62 |
| 1 month | 79.41 | | 87.62 |
| Current year | 64.95 | | 87.62 |
| 1 year | 64.95 | | 87.62 |
| 3 years | 44.61 | | 87.62 |
| 5 years | 44.61 | | 149 |
| 10 years | 44.61 | | 879.29 |
| Manager | Title | Age | Since |
|---|---|---|---|
Gilles Martin
CEO | Chief Executive Officer | 63 | 01/01/1987 |
Laurent Lebras
DFI | Director of Finance/CFO | - | 01/01/2015 |
Christian Wurst
PRN | Corporate Officer/Principal | 54 | 01/10/2019 |
| Director | Title | Age | Since |
|---|---|---|---|
Gilles Martin
CHM | Chairman | 63 | 01/01/1987 |
Yves-Loïc Martin
BRD | Director/Board Member | 60 | 01/01/2015 |
Valérie Hanote
BRD | Director/Board Member | 60 | 01/01/1990 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.31% | +0.52% | - | - | 14.96B | |
| +0.35% | +0.86% | -1.14% | +27.17% | 45.91B | |
| -0.32% | +4.61% | +43.90% | +26.98% | 44.25B | |
| -4.36% | -5.66% | +338.30% | +516.88% | 41.99B | |
| +0.46% | -0.83% | +6.38% | +73.76% | 39.58B | |
| -0.17% | -3.22% | +10.29% | +38.69% | 31.08B | |
| -0.65% | +5.14% | +25.61% | +120.17% | 17.21B | |
| +3.30% | -5.03% | - | - | 16.27B | |
| +2.22% | +7.67% | +21.63% | +38.79% | 14.96B | |
| +0.86% | +9.05% | +0.47% | -33.54% | 13.42B | |
| Average | -0.07% | +1.18% | +55.68% | +101.11% | 29.41B | |
| Weighted average by Cap. | -0.42% | +0.31% | +70.21% | +122.65% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 7.58B 8.75B 7.17B 6.51B 12.2B 839B 12.27B 85.57B 33.06B 426B 32.87B 32.14B 1,357B | 8B 9.23B 7.56B 6.86B 12.86B 885B 12.94B 90.24B 34.87B 449B 34.67B 33.9B 1,431B |
| Net income | 531M 613M 502M 456M 854M 58.77B 859M 5.99B 2.31B 29.81B 2.3B 2.25B 95.02B | 660M 761M 624M 566M 1.06B 73.03B 1.07B 7.44B 2.88B 37.04B 2.86B 2.8B 118B |
| Net Debt | 3.37B 3.88B 3.18B 2.89B 5.41B 373B 5.45B 37.98B 14.68B 189B 14.59B 14.27B 602B | 3.03B 3.5B 2.87B 2.6B 4.88B 336B 4.91B 34.23B 13.23B 170B 13.15B 12.86B 543B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 16/09/26 | $84.33 | -2.31% | 826 |
| 15/09/26 | $86.32 | +1.58% | 5,291 |
| 14/09/26 | $84.98 | +1.77% | 534 |
| 11/09/26 | $83.50 | +0.63% | 239 |
| 10/09/26 | $82.98 | -1.09% | 140 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ERF Stock
- ERFSF Stock
Select your edition
All financial news and data tailored to specific country editions
